Abingdon Health (LON:ABDX) Hits New 1-Year Low – Time to Sell?

Abingdon Health Plc (LON:ABDX) reached a new 52-week low during trading on Friday . The company traded as low as GBX 6.50 ($0.08) and last traded at GBX 6.82 ($0.09), with a volume of 49750 shares trading hands. The stock had previously closed at GBX 6.75 ($0.09).

Abingdon Health Stock Up 1.0 %

The firm has a market capitalization of £13.21 million, a PE ratio of -16.58 and a beta of 0.13. The business’s fifty day moving average price is GBX 7.60 and its 200 day moving average price is GBX 8.14. The company has a quick ratio of 1.96, a current ratio of 1.95 and a debt-to-equity ratio of 46.64.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.